Centronuclear Myopathy Market: By Types, By Treatment, By Diagnosis, By End Users and Geography

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Centronuclear Myopathy Market Size, Share, Growth, Trends, and Global Industry Analysis: By Types (Myotubular Myopathy, Autosomal Centronuclear Myopathies, and Others), By Treatment (Night-time Ventilation, Gastrostomy, Physiotherapy, Antibiotics, and Others), By Diagnosis (Muscle Biopsy, Molecular Testing, and Others), By End Users (Hospitals, Specialty Clinics, Homecare, Others) and Region

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Centronuclear Myopathy Market  is poised to grow at a CAGR of 4.5% over 2024-2030. Centronuclear myopathies (CNM) are a group of congenital myopathies, that occur mainly because of mutation in the MTM1 gene, where cell nuclei are abnormally located in the center of muscle cells instead of their normal location at the periphery, symptoms include severe hypotonia, hypoxia requiring breathing assistance, and scaphocephaly. As per a research report, the X-liked form of centronuclear myopathy has an incidence rate of 1 per 50,000 male births. The rise in the demand and need for novel therapeutics will act as the growth driver for the market. However, the limited availability of medicinal treatment options due to the low prevalence of centronuclear myopathy is the factor hindering the market growth. Financial support from the government and an increase in strategic collaborations between the market players are huge growth opportunities for the expansion of the market.

Centronuclear Myopathy Market Key Developments:
  • In Nov 2021, Dynacure and Nippon Shinyaku entered into a long-term strategic development and commercialization agreement for Dynacure’s DYN-101, for the treatment of centronuclear myopathies.
  • In Jan 2023, ARMGO Pharma’s ARM 210 was in phase-I development for congenital structural myopathies in the USA.

summary download arrow Download Free Sample

Centronuclear Myopathy Market Summary

Study Period

2024-2030

Base Year

N/A

CAGR

x%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Centronuclear Myopathy Market Dynamics

Companies and academics are working to assess challenges and seek opportunities that could influence CNM research and development, primarily focusing on novel approaches. Furthermore, the emerging therapies for centronuclear myopathies such as ARM210, DYN101, and AT-132, which are currently in the clinical investigation phases will participate in the growth of the market. Thus, the increased awareness, research, and development for centronuclear myopathy will lead to the growth of the market within the forecast period, whereas, fewer approvals of drugs from the regulatory authorities could pose as restraining factor in the market growth.

Centronuclear Myopathy Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market CAGR

x%

By Type

  • Myotubular Myopathy
  • Autosomal Centronuclear Myopathies
  • Others

By Treatment Type

  • Night-time Ventilation
  • Gastrostomy
  • Physiotherapy
  • Antibiotics
  • Others

By Diagnosis

  • Muscle Biopsy
  • Molecular Testing
  • Others

By End User

  • Hospitals
  • Clinics
  • Homecare
  • Others

Key Features of the Report

  • The centronuclear myopathy market report provides granular level information about the market size, regional market share, historic market (2019-2023) and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The Centronuclear Myopathy market was valued at US$ XX million in 2022 and is expected to grow at a XX% CAGR over the forecast period 2023 – 2029.

Financial support from the government and an increase in strategic collaborations between the market players are the key opportunities for the Centronuclear Myopathy market.

The rise in the demand and need for novel therapeutics is the driver in the Centronuclear Myopathy market.

Audentes Therapeutics, Ionis Pharmaceuticals, Inc., Dynacure, Valerion Therapeutics, Biophytis, ARMGO Pharma Inc., Stealth BioTherapeutics Inc., Novartis AG, CENTOGENE AG, Sanofi, KalVista Pharmaceuticals, Pfizer Inc., and GlaxoSmithKline plc. are a few companies operating in the Centronuclear Myopathy market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Centronuclear Myopathy Market Introduction 
2.1.Global Centronuclear Myopathy Market  - Taxonomy
2.2.Global Centronuclear Myopathy Market  - Definitions
2.2.1.Type
2.2.2.Treatment Type
2.2.3.Diagnosis
2.2.4.End User
2.2.5.Region
3.Global Centronuclear Myopathy Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Centronuclear Myopathy Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Centronuclear Myopathy Market  By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Myotubular Myopathy
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Autosomal Centronuclear Myopathies
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Others
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Centronuclear Myopathy Market  By Treatment Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Night-time Ventilation
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Gastrostomy
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Physiotherapy
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Antibiotics
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Centronuclear Myopathy Market  By Diagnosis, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Muscle Biopsy
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Molecular Testing
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Centronuclear Myopathy Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Hospitals
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Clinics
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Homecare
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Others
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9.Global Centronuclear Myopathy Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Centronuclear Myopathy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Myotubular Myopathy
10.1.2.Autosomal Centronuclear Myopathies
10.1.3.Others
10.2.  Treatment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Night-time Ventilation
10.2.2.Gastrostomy
10.2.3.Physiotherapy
10.2.4.Antibiotics
10.2.5.Others
10.3.  Diagnosis Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Muscle Biopsy
10.3.2.Molecular Testing
10.3.3.Others
10.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospitals
10.4.2.Clinics
10.4.3.Homecare
10.4.4.Others
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Centronuclear Myopathy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Myotubular Myopathy
11.1.2.Autosomal Centronuclear Myopathies
11.1.3.Others
11.2.  Treatment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Night-time Ventilation
11.2.2.Gastrostomy
11.2.3.Physiotherapy
11.2.4.Antibiotics
11.2.5.Others
11.3.  Diagnosis Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Muscle Biopsy
11.3.2.Molecular Testing
11.3.3.Others
11.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospitals
11.4.2.Clinics
11.4.3.Homecare
11.4.4.Others
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
12.Asia Pacific (APAC) Centronuclear Myopathy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Myotubular Myopathy
12.1.2.Autosomal Centronuclear Myopathies
12.1.3.Others
12.2.  Treatment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Night-time Ventilation
12.2.2.Gastrostomy
12.2.3.Physiotherapy
12.2.4.Antibiotics
12.2.5.Others
12.3.  Diagnosis Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Muscle Biopsy
12.3.2.Molecular Testing
12.3.3.Others
12.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospitals
12.4.2.Clinics
12.4.3.Homecare
12.4.4.Others
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Centronuclear Myopathy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Myotubular Myopathy
13.1.2.Autosomal Centronuclear Myopathies
13.1.3.Others
13.2.  Treatment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Night-time Ventilation
13.2.2.Gastrostomy
13.2.3.Physiotherapy
13.2.4.Antibiotics
13.2.5.Others
13.3.  Diagnosis Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Muscle Biopsy
13.3.2.Molecular Testing
13.3.3.Others
13.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospitals
13.4.2.Clinics
13.4.3.Homecare
13.4.4.Others
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Centronuclear Myopathy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Myotubular Myopathy
14.1.2.Autosomal Centronuclear Myopathies
14.1.3.Others
14.2.  Treatment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Night-time Ventilation
14.2.2.Gastrostomy
14.2.3.Physiotherapy
14.2.4.Antibiotics
14.2.5.Others
14.3.  Diagnosis Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Muscle Biopsy
14.3.2.Molecular Testing
14.3.3.Others
14.4.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospitals
14.4.2.Clinics
14.4.3.Homecare
14.4.4.Others
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Audentes Therapeutics
15.2.2.Ionis Pharmaceuticals, Inc.
15.2.3.Dynacure
15.2.4.Valerion Therapeutics
15.2.5.Biophytis
15.2.6.ARMGO Pharma Inc.
15.2.7.Stealth BioTherapeutics Inc.
15.2.8.Novartis AG
15.2.9.CENTOGENE AG
15.2.10.Sanofi
15.2.11.KalVista Pharmaceuticals
15.2.12.Pfizer Inc.
15.2.13.GlaxoSmithKline plc.
15.2.14.AstraZeneca
15.2.15.Medtronic
15.2.16.Roche Ltd,
15.2.17.Amgen Inc.
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Audentes Therapeutics
  • Ionis Pharmaceuticals, Inc.
  • Dynacure
  • Valerion Therapeutics
  • Biophytis
  • ARMGO Pharma Inc.
  • Stealth BioTherapeutics Inc.
  • Novartis AG
  • CENTOGENE AG
  • Sanofi
  • KalVista Pharmaceuticals
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • AstraZeneca
  • Medtronic
  • Roche Ltd,
  • Amgen Inc.

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market